174 related articles for article (PubMed ID: 14632753)
21. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
[TBL] [Abstract][Full Text] [Related]
22. CD56
Judge CJ; Kostadinova L; Sherman KE; Butt AA; Falck-Ytter Y; Funderburg NT; Landay AL; Lederman MM; Sieg SF; Sandberg JK; Anthony DD
J Leukoc Biol; 2017 Jul; 102(1):171-184. PubMed ID: 28400540
[TBL] [Abstract][Full Text] [Related]
23. Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
Desalegn G; Tsegaye A; Gebreegziabiher D; Aseffa A; Howe R
BMC Immunol; 2019 Oct; 20(1):35. PubMed ID: 31601184
[TBL] [Abstract][Full Text] [Related]
24. CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.
Milush JM; López-Vergès S; York VA; Deeks SG; Martin JN; Hecht FM; Lanier LL; Nixon DF
Retrovirology; 2013 Dec; 10():158. PubMed ID: 24351015
[TBL] [Abstract][Full Text] [Related]
25. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
26. The abnormal distribution of NK cell subsets before HAART treatment may be related to the level of immune reconstitution in HIV patient.
Sun S; Kong W; Cui X; Lin Y; Lu B; Pan Y; Huang J; Hu X
Int Immunopharmacol; 2021 Jul; 96():107784. PubMed ID: 34162148
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
[TBL] [Abstract][Full Text] [Related]
28. Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART.
Sutherland R; Yang H; Scriba TJ; Ondondo B; Robinson N; Conlon C; Suttill A; McShane H; Fidler S; McMichael A; Dorrell L
AIDS; 2006 Apr; 20(6):821-9. PubMed ID: 16549965
[TBL] [Abstract][Full Text] [Related]
29. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.
Mavilio D; Lombardo G; Benjamin J; Kim D; Follman D; Marcenaro E; O'Shea MA; Kinter A; Kovacs C; Moretta A; Fauci AS
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2886-91. PubMed ID: 15699323
[TBL] [Abstract][Full Text] [Related]
30. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
Powles T; Imami N; Nelson M; Gazzard BG; Bower M
AIDS; 2002 Mar; 16(4):531-6. PubMed ID: 11872995
[TBL] [Abstract][Full Text] [Related]
31. Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.
Naluyima P; Eller MA; Laeyendecker O; Quinn TC; Serwadda D; Sewankambo NK; Gray RH; Michael NL; Wabwire-Mangen F; Robb ML; Sandberg JK
AIDS; 2014 Jun; 28(9):1273-8. PubMed ID: 24959961
[TBL] [Abstract][Full Text] [Related]
32. Enhanced survival and potent expansion of the natural killer cell population of HIV-infected individuals by exogenous interleukin-15.
Naora H; Gougeon ML
Immunol Lett; 1999 Jun; 68(2-3):359-67. PubMed ID: 10424444
[TBL] [Abstract][Full Text] [Related]
33. Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.
Liberati AM; De Angelis V; Fizzotti M; Schippa M; Cecchini M; Adiuto D; Di Clemente F; Palmisano L; Micozzi E; Zuccaccia M
Cancer Immunol Immunother; 1994 May; 38(5):323-31. PubMed ID: 7512888
[TBL] [Abstract][Full Text] [Related]
34. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
[TBL] [Abstract][Full Text] [Related]
35. Increased natural killer cell activity in viremic HIV-1 infection.
Alter G; Malenfant JM; Delabre RM; Burgett NC; Yu XG; Lichterfeld M; Zaunders J; Altfeld M
J Immunol; 2004 Oct; 173(8):5305-11. PubMed ID: 15470077
[TBL] [Abstract][Full Text] [Related]
36. HIV infection deregulates Tim-3 expression on innate cells: combination antiretroviral therapy results in partial restoration.
Finney CA; Ayi K; Wasmuth JD; Sheth PM; Kaul R; Loutfy M; Kain KC; Serghides L
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):161-7. PubMed ID: 23314411
[TBL] [Abstract][Full Text] [Related]
37. Human natural killer cells expressing the memory-associated marker CD45RO from tuberculous pleurisy respond more strongly and rapidly than CD45RO- natural killer cells following stimulation with interleukin-12.
Fu X; Liu Y; Li L; Li Q; Qiao D; Wang H; Lao S; Fan Y; Wu C
Immunology; 2011 Sep; 134(1):41-9. PubMed ID: 21711347
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection.
Mavilio D; Lombardo G; Kinter A; Fogli M; La Sala A; Ortolano S; Farschi A; Follmann D; Gregg R; Kovacs C; Marcenaro E; Pende D; Moretta A; Fauci AS
J Exp Med; 2006 Oct; 203(10):2339-50. PubMed ID: 17000867
[TBL] [Abstract][Full Text] [Related]
39. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion.
Jewett A; Bonavida B
Cell Immunol; 1994 Apr; 154(1):273-86. PubMed ID: 7907529
[TBL] [Abstract][Full Text] [Related]
40. Influence of interleukin-15 on CD8+ natural killer cells in human immunodeficiency virus type 1-infected chimpanzees.
Rodriguez AR; Arulanandam BP; Hodara VL; McClure HM; Cobb EK; Salas MT; White R; Murthy KK
J Gen Virol; 2007 Feb; 88(Pt 2):641-651. PubMed ID: 17251583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
